Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer

NCT06877416 · clinicaltrials.gov ↗

RECRUITING

Status

700

Enrollment

OTHER

Sponsor class

Conditions

Antibody-drug Conjugates
HER2-low Breast Cancer
Breast Neoplasms

Interventions

OTHER: Non-intervention research

Sponsor

Sun Yat-sen University